Trial intelligence / Profile preview

Neoadjuvant Imatinib in DFSP

NCT00243191Phase 2Completed

Sponsor
Sarcoma Alliance for Research through Collaboration
Start
May 2006
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of imatinib in dermatofibrosarcoma protuberans (DFSP), sponsored by Sarcoma Alliance for Research through Collaboration. Started May 2006; status: completed.

02

Drugs

03

Conditions

dermatofibrosarcoma protuberans (DFSP)

Beyond the preview

Go deeper on NCT00243191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00243191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call